Guobin Wu
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 21
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Liver Disease and Transplantation 2
- Oncology 7
- Cancer Cells and Metastasis 2
- Cancer-related Molecular Pathways 2
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Mengchao Wu (4 shared papers)Jian Zhao (4 shared papers)Rongyun Mai (12 shared papers)Tao Bai (10 shared papers)Jiazhou Ye (14 shared papers)Anmin Liang (4 shared papers)Bin Lü (3 shared papers)Yajun Guo (3 shared papers)
- Journals
- Cancer Management and Research (2 papers)BMC Cancer (2 papers)Hepatology (2 papers)Therapeutics and Clinical Risk Management (2 papers)Gastroenterology (2 papers)
- Partner nations
- ChinaUnited KingdomSwitzerland
In The Last Decade
Guobin Wu
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Hepatology 358
- Cancer Research 196
- Oncology 148
- Health Informatics 15
- Molecular Biology 279
Countries citing papers authored by Guobin Wu
This map shows the geographic impact of Guobin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Wu more than expected).
Fields of papers citing papers by Guobin Wu
This network shows the impact of papers produced by Guobin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Wu. The network helps show where Guobin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guobin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 125 | |
| 2 | 2008 | 120 | |
| 3 | 2009 | 98 | |
| 4 | 2015 | 73 | |
| 5 | 2021 | 73 | |
| 6 | 2008 | 61 | |
| 7 | 2012 | 61 | |
| 8 | 2008 | 47 | |
| 9 | 2017 | 47 | |
| 10 | 2020 | 47 | |
| 11 | 2019 | 46 | |
| 12 | 2010 | 41 | |
| 13 | 2008 | 39 | |
| 14 | 2019 | 32 | |
| 15 | 2024 | 28 | |
| 16 | 2015 | 27 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 20 | |
| 19 | 2022 | 18 | |
| 20 | 2024 | 16 |
About Guobin Wu
Guobin Wu is a scholar working on Hepatology, Oncology, Cancer Research, Molecular Biology and Rheumatology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cancer-related molecular mechanisms research (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer Cells and Metastasis (2 papers), Cancer-related Molecular Pathways (2 papers), Liver Disease and Transplantation (2 papers), Bone and Dental Protein Studies (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Hepatology (358 citations), Cancer Research (196 citations), Oncology (148 citations), Health Informatics (15 citations) and Molecular Biology (279 citations). Guobin Wu has collaborated with scholars based in China, United Kingdom and Switzerland. Frequent co-authors include Mengchao Wu, Jian Zhao, Rongyun Mai, Tao Bai, Jiazhou Ye, Anmin Liang, Bin Lü, Yajun Guo, Le‐Qun Li and Yajun Guo. Their work appears in journals such as Cancer Management and Research, BMC Cancer, Hepatology, Therapeutics and Clinical Risk Management and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.